{"title":"第一人称,瓦伦蒂娜·祖科","authors":"","doi":"10.1242/dmm.050313","DOIUrl":null,"url":null,"abstract":"\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Valentina Zuco is first author on ‘ Effects of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft’, published in DMM. Valentina is a scientist in the lab of Nadia Zaffaroni at Fondazione IRCCS Istituto Tumori, Milan, Italy, investigating patient-derived tumor models to identify new therapeutic strategies for patients with rare cancers to be translated into clinical trials.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First person – Valentina Zuco\",\"authors\":\"\",\"doi\":\"10.1242/dmm.050313\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Valentina Zuco is first author on ‘ Effects of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft’, published in DMM. Valentina is a scientist in the lab of Nadia Zaffaroni at Fondazione IRCCS Istituto Tumori, Milan, Italy, investigating patient-derived tumor models to identify new therapeutic strategies for patients with rare cancers to be translated into clinical trials.\",\"PeriodicalId\":141347,\"journal\":{\"name\":\"Disease Models & Mechanisms\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Models & Mechanisms\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1242/dmm.050313\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Models & Mechanisms","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1242/dmm.050313","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Valentina Zuco is first author on ‘ Effects of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft’, published in DMM. Valentina is a scientist in the lab of Nadia Zaffaroni at Fondazione IRCCS Istituto Tumori, Milan, Italy, investigating patient-derived tumor models to identify new therapeutic strategies for patients with rare cancers to be translated into clinical trials.